Amit A Gohil, MD
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 24
- 5 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
24 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Gohil’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
24 of 24 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A102212 · Current
Licensed to practise in California · since 2007 · expires 2027-12-31 · University of Edinburgh Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$58,889
Medicare paid this office $58,889 for 219 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 87 | $41,197 | $186 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 66 | $7,066 | $69 |
| Short return visit (20+ min) | 64 | $4,281 | $55 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $1,029 | $74 |
| Test to determine lung volumes using sensors | 16 | $160 | $10 |
See all 7 services
| Critical care, first 30-74 minutes | 87 | $41,197 | $186 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 66 | $7,066 | $69 |
| Short return visit (20+ min) | 64 | $4,281 | $55 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $1,029 | $74 |
| Test to determine lung volumes using sensors | 16 | $160 | $10 |
| Test to examine how well the lungs exchange gases | 16 | $118 | $7 |
| Test to measure expiratory airflow and volume | 14 | $87 | $6 |
Who their Medicare patients are
219 Original Medicare patients in 2024. Average age 72 · Under 65 15% · 85 and older 16% · Women 51% · Also on Medicaid 80% · Health risk score 2.92. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 55% · COPD 43% · Heart failure 41% · Coronary heart disease 39% · Chronic kidney disease 38% · Atrial fibrillation 34% · Dementia 26% · Depression 25% · Stroke 24% · Cancer 18%.
The office billed $639,010, Medicare allowed $75,144 and paid $58,889; for 525 services of 27 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 219 | 525 | 72 | 2.92 | $639,010 | $58,889 |
| 2023 | 211 | 492 | 71 | 2.42 | $440,626 | $44,380 |
| 2022 | 192 | 398 | 71 | 2.21 | $403,537 | $43,731 |
| 2021 | 166 | 359 | 71 | 2.53 | $354,475 | $44,039 |
| 2020 | 179 | 409 | 70 | 3.19 | $428,457 | $53,046 |
| 2019 | 237 | 508 | 70 | 2.45 | $401,761 | $43,778 |
| 2018 | 267 | 624 | 69 | 2.54 | $544,815 | $60,613 |
| 2017 | 215 | 480 | 70 | 2.53 | $408,599 | $48,840 |
| 2016 | 254 | 547 | 68 | 2.28 | $369,989 | $51,837 |
| 2015 | 232 | 496 | 68 | 2.09 | $317,992 | $45,014 |
| 2014 | 298 | 595 | 69 | 1.97 | $262,249 | $41,702 |
| 2013 | 256 | 477 | 68 | 1.95 | $211,084 | $37,667 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Critical care, first 30-74 minutes | 49 | $27,761 | $198 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 47 | $6,038 | $75 |
| Short return visit (20+ min) | 69 | $4,575 | $55 |
| Test to determine lung volumes using sensors | 44 | $449 | $10 |
| Test to examine how well the lungs exchange gases | 38 | $299 | $8 |
| Test to measure expiratory airflow and volume | 36 | $254 | $7 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 17 | $150 | $9 |
2022: 8 services
| Critical care, first 30-74 minutes | 56 | $30,520 | $221 |
| Short return visit (20+ min) | 66 | $4,008 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $3,270 | $73 |
| Return visit (30+ min) | 16 | $1,374 | $86 |
| Telephone medical discussion with physician, 5-10 minutes | 18 | $402 | $21 |
| Test to determine lung volumes using sensors | 19 | $166 | $9 |
| Test to examine how well the lungs exchange gases | 18 | $122 | $7 |
| Test to measure expiratory airflow and volume | 15 | $91 | $6 |
2021: 5 services
| Critical care, first 30-74 minutes | 47 | $29,446 | $232 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 42 | $5,376 | $78 |
| Short return visit (20+ min) | 45 | $3,382 | $61 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,629 | $109 |
| Telephone medical discussion with physician, 5-10 minutes | 25 | $872 | $32 |
2020: 4 services
| Critical care, first 30-74 minutes | 56 | $38,959 | $236 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $4,958 | $76 |
| Telephone medical discussion with physician, 11-20 minutes | 50 | $2,627 | $48 |
| Short return visit (20+ min) | 32 | $1,192 | $30 |
2019: 8 services
| Critical care, first 30-74 minutes | 53 | $23,065 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 47 | $6,297 | $66 |
| Short return visit (20+ min) | 101 | $5,506 | $43 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 28 | $2,315 | $83 |
| Test to determine lung volumes using sensors | 20 | $170 | $8 |
| Test to measure expiratory airflow and volume | 18 | $109 | $6 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 11 | $108 | $10 |
| Test to examine how well the lungs exchange gases | 17 | $100 | $6 |
2018: 10 services
| Critical care, first 30-74 minutes | 58 | $35,246 | $192 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 69 | $7,350 | $64 |
| Short return visit (20+ min) | 98 | $5,566 | $41 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,566 | $112 |
| Emergency department visit with moderate level of medical decision making | 21 | $1,919 | $91 |
| New patient visit (45+ min) | 15 | $1,136 | $76 |
| Return visit (30+ min) | 15 | $706 | $47 |
| Test to determine lung volumes using sensors | 12 | $111 | $9 |
| Test to measure expiratory airflow and volume | 15 | $91 | $6 |
| Test to examine how well the lungs exchange gases | 12 | $82 | $7 |
2017: 5 services
| Critical care, first 30-74 minutes | 60 | $30,867 | $195 |
| Short return visit (20+ min) | 101 | $5,393 | $39 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $2,740 | $64 |
| Return visit (30+ min) | 24 | $1,500 | $58 |
| Test to determine lung volumes using sensors | 11 | $100 | $9 |
2016: 9 services
| Critical care, first 30-74 minutes | 65 | $30,743 | $191 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 69 | $5,585 | $63 |
| Short return visit (20+ min) | 87 | $3,849 | $38 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $2,798 | $108 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,499 | $93 |
| Return visit (30+ min) | 24 | $1,417 | $59 |
| Test to measure expiratory airflow and volume | 24 | $124 | $5 |
| Test to determine lung volumes using sensors | 17 | $100 | $6 |
| Test to examine how well the lungs exchange gases | 15 | $74 | $5 |
2015: 8 services
| Critical care, first 30-74 minutes | 64 | $27,947 | $186 |
| Short return visit (20+ min) | 96 | $5,127 | $38 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $3,593 | $62 |
| Return visit (30+ min) | 37 | $2,164 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $1,999 | $91 |
| Test to determine lung volumes using sensors | 16 | $141 | $9 |
| Test to measure expiratory airflow and volume | 20 | $118 | $6 |
| Test to examine how well the lungs exchange gases | 13 | $80 | $6 |
2014: 9 services
| Critical care, first 30-74 minutes | 57 | $22,201 | $193 |
| Short return visit (20+ min) | 152 | $7,482 | $39 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 48 | $5,411 | $64 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,582 | $122 |
| Return visit (30+ min) | 17 | $614 | $36 |
| Test to determine lung volumes using sensors | 31 | $273 | $9 |
| Test to measure expiratory airflow and volume | 30 | $220 | $7 |
| Test to examine how well the lungs exchange gases | 31 | $204 | $6 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 21 | $153 | $7 |
2013: 8 services
| Critical care, first 30-74 minutes | 58 | $22,205 | $190 |
| Short return visit (20+ min) | 119 | $5,869 | $38 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 51 | $4,980 | $62 |
| Return visit (30+ min) | 15 | $1,072 | $67 |
| Test to determine lung volumes using sensors | 21 | $243 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 17 | $207 | $12 |
| Test to examine how well the lungs exchange gases | 21 | $170 | $8 |
| Test to measure expiratory airflow and volume | 19 | $122 | $6 |
Medicaid work
$19,588 in 2024
Medicaid paid $19,588 for 1,194 billed services this clinician did in 2024, up to 50 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 378 | $16,087 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 184 | $2,073 |
| Short return visit (20+ min) | 174 | $1,141 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 49 | $114 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 38 | $98 |
| Diffusing capacity | 46 | $76 |
| Medication list documented in medical record (COA) | 139 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 30 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 15 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 19 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 108 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 14 | $0 |
| 2024 | 1,194 | 12 | 50 | $19,588 |
| 2023 | 1,089 | 7 | 57 | $10,145 |
| 2022 | 552 | 6 | 26 | $8,052 |
| 2021 | 310 | 4 | 25 | $11,295 |
| 2020 | 175 | 6 | 25 | $4,129 |
| 2019 | 618 | 6 | 32 | $9,238 |
| 2018 | 746 | 8 | 32 | $15,417 |
See the largest Medicaid services in earlier years
2023
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 239 | $7,661 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 149 | $1,052 |
| Short return visit (20+ min) | 196 | $770 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 163 | $260 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 151 | $212 |
| Diffusing capacity | 170 | $191 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 21 | $0 |
2022
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 188 | $6,778 |
| Short return visit (20+ min) | 179 | $933 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 18 | $137 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 56 | $82 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 56 | $76 |
| Diffusing capacity | 55 | $45 |
2021
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 143 | $9,729 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 74 | $901 |
| Short return visit (20+ min) | 80 | $505 |
| IP/OBS CONSLTJ NEW/EST PT LOW MDM 45 MINUTES | 13 | $159 |
2020
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 37 | $3,139 |
| Short return visit (20+ min) | 78 | $666 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 20 | $239 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 14 | $41 |
| Diffusing capacity | 14 | $22 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 12 | $22 |
2019
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 156 | $7,108 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 100 | $1,427 |
| Short return visit (20+ min) | 211 | $439 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 57 | $112 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 52 | $87 |
| Diffusing capacity | 42 | $66 |
2018
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 252 | $11,454 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 177 | $2,440 |
| Short return visit (20+ min) | 219 | $969 |
| EMERGENCY DEPT VISIT MOD MDM | 12 | $380 |
| EVALUATION OF WHEEZING | 19 | $73 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 23 | $44 |
| Diffusing capacity | 23 | $29 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 21 | $27 |
Drugs they prescribed that Part D paid
$322,142
Pharmacies billed $322,142 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
233 generic and 258 brand-name prescriptions · $322,142 in drug cost · 20 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ofev | 14 | $173,585 | $12,399 |
| Incruse Ellipta | 20 | $6,626 | $331 |
| Breo Ellipta | 16 | $5,821 | $364 |
| Budesonide-Formoterol | 22 | $5,000 | $227 |
| Advair Hfa | 12 | $4,436 | $370 |
See all 14 drugs
| Ofev | 14 | $173,585 | $12,399 |
| Incruse Ellipta | 20 | $6,626 | $331 |
| Breo Ellipta | 16 | $5,821 | $364 |
| Budesonide-Formoterol | 22 | $5,000 | $227 |
| Advair Hfa | 12 | $4,436 | $370 |
| Fluticasone-Salmeterol | 30 | $3,708 | $124 |
| Albuterol Sulfate Hfa | 66 | $3,370 | $51 |
| Symbicort | 11 | $3,145 | $286 |
| Fluticasone Propionate | 40 | $339 | $8 |
| Azithromycin | 16 | $291 | $18 |
| Omeprazole | 19 | $260 | $14 |
| Prednisone | 23 | $123 | $5 |
| Montelukast | 18 | $94 | $5 |
| Furosemide | 18 | $33 | $2 |
Year by year
| 2024 | 491 | 98 | None | 53% | $322,142 |
| 2023 | 500 | 109 | 0% (0) | 67% | $609,994 |
| 2022 | 497 | 112 | None | 65% | $392,099 |
| 2021 | 417 | 88 | 0% (0) | 68% | $218,737 |
| 2020 | 448 | 92 | 0% (0) | 72% | $133,876 |
| 2019 | 570 | 116 | 0% (0) | 74% | $204,035 |
| 2018 | 503 | 118 | 0% (0) | 72% | $141,909 |
| 2017 | 531 | 116 | None | 64% | $107,161 |
| 2016 | 620 | 118 | None | 58% | $120,115 |
| 2015 | 625 | 135 | None | 67% | $131,871 |
| 2014 | 443 | 111 | None | 73% | $93,994 |
| 2013 | 284 | 77 | None | 68% | $58,667 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Ofev | 27 | $337,139 | $12,487 |
| Nucala | 25 | $85,902 | $3,436 |
| Ambrisentan | 14 | $52,076 | $3,720 |
| Advair Diskus | 45 | $25,712 | $571 |
| Spiriva Handihaler | 25 | $24,627 | $985 |
| Symbicort | 52 | $22,790 | $438 |
| Spiriva Respimat | 11 | $9,712 | $883 |
| Atrovent Hfa | 14 | $9,595 | $685 |
| Advair Hfa | 14 | $7,351 | $525 |
| Breo Ellipta | 13 | $5,552 | $427 |
| Incruse Ellipta | 14 | $5,369 | $383 |
| Flovent Hfa | 13 | $5,030 | $387 |
| Albuterol Sulfate Hfa | 40 | $2,140 | $53 |
| Ventolin Hfa | 17 | $1,634 | $96 |
| Azithromycin | 17 | $681 | $40 |
| Montelukast | 21 | $493 | $23 |
| Fluticasone Propionate | 30 | $441 | $15 |
| Omeprazole | 18 | $339 | $19 |
| Prednisone | 18 | $166 | $9 |
2022: 17 drugs
| Ofev | 16 | $183,153 | $11,447 |
| Nucala | 19 | $54,495 | $2,868 |
| Spiriva Handihaler | 45 | $36,345 | $808 |
| Symbicort | 82 | $36,329 | $443 |
| Advair Diskus | 17 | $12,293 | $723 |
| Spiriva Respimat | 17 | $11,961 | $704 |
| Breo Ellipta | 18 | $7,297 | $405 |
| Atrovent Hfa | 13 | $6,829 | $525 |
| Incruse Ellipta | 16 | $6,123 | $383 |
| Albuterol Sulfate Hfa | 37 | $2,169 | $59 |
| Ventolin Hfa | 15 | $1,185 | $79 |
| Montelukast | 22 | $446 | $20 |
| Azithromycin | 16 | $354 | $22 |
| Omeprazole | 15 | $340 | $23 |
| Fluticasone Propionate | 16 | $195 | $12 |
| Prednisone | 18 | $131 | $7 |
| Furosemide | 13 | $128 | $10 |
2021: 11 drugs
| Symbicort | 87 | $35,352 | $406 |
| Spiriva | 45 | $29,835 | $663 |
| Advair Diskus | 14 | $13,699 | $979 |
| Breo Ellipta | 19 | $6,672 | $351 |
| Atrovent Hfa | 15 | $6,265 | $418 |
| Ventolin Hfa | 30 | $1,957 | $65 |
| Albuterol Sulfate Hfa | 11 | $989 | $90 |
| Metolazone | 12 | $573 | $48 |
| Fluticasone Propionate | 21 | $262 | $12 |
| Montelukast | 26 | $251 | $10 |
| Prednisone | 11 | $88 | $8 |
2020: 14 drugs
| Spiriva | 51 | $33,061 | $648 |
| Symbicort | 70 | $32,016 | $457 |
| Advair Diskus | 28 | $20,087 | $717 |
| Breo Ellipta | 20 | $7,121 | $356 |
| Daliresp | 12 | $7,070 | $589 |
| Incruse Ellipta | 13 | $5,030 | $387 |
| Ventolin Hfa | 26 | $2,271 | $87 |
| Albuterol Sulfate Hfa | 28 | $2,129 | $76 |
| Sildenafil Citrate | 11 | $1,097 | $100 |
| Azithromycin | 19 | $552 | $29 |
| Metolazone | 13 | $502 | $39 |
| Fluticasone Propionate | 13 | $180 | $14 |
| Gabapentin | 16 | $131 | $8 |
| Pantoprazole | 11 | $107 | $10 |
2019: 15 drugs
| Spiriva | 83 | $48,190 | $581 |
| Symbicort | 68 | $28,103 | $413 |
| Advair Diskus | 47 | $25,480 | $542 |
| Flovent Hfa | 20 | $7,278 | $364 |
| Breo Ellipta | 14 | $7,081 | $506 |
| Atrovent Hfa | 17 | $6,415 | $377 |
| Stiolto Respimat | 11 | $4,026 | $366 |
| Dulera | 13 | $3,957 | $304 |
| Ventolin Hfa | 38 | $3,061 | $81 |
| Albuterol Sulfate Hfa | 27 | $1,089 | $40 |
| Metolazone | 12 | $709 | $59 |
| Fluticasone Propionate | 22 | $341 | $16 |
| Azithromycin | 15 | $214 | $14 |
| Prednisone | 24 | $191 | $8 |
| Gabapentin | 11 | $97 | $9 |
2018: 11 drugs
| Spiriva | 59 | $26,569 | $450 |
| Advair Diskus | 43 | $24,338 | $566 |
| Symbicort | 59 | $19,064 | $323 |
| Flovent Hfa | 33 | $12,073 | $366 |
| Incruse Ellipta | 15 | $4,431 | $295 |
| Ventolin Hfa | 49 | $3,488 | $71 |
| Proair Hfa | 24 | $1,402 | $58 |
| Metolazone | 12 | $709 | $59 |
| Prednisone | 37 | $390 | $11 |
| Fluticasone Propionate | 21 | $293 | $14 |
| Montelukast | 12 | $91 | $8 |
2017: 14 drugs
| Spiriva | 51 | $30,523 | $598 |
| Advair Diskus | 43 | $20,391 | $474 |
| Symbicort | 53 | $14,335 | $270 |
| Flovent Hfa | 21 | $7,532 | $359 |
| Dulera | 18 | $7,214 | $401 |
| Qvar | 23 | $4,693 | $204 |
| Daliresp | 12 | $3,045 | $254 |
| Ventolin Hfa | 41 | $2,689 | $66 |
| Proair Hfa | 26 | $1,571 | $60 |
| Azithromycin | 28 | $501 | $18 |
| Prednisone | 35 | $388 | $11 |
| Fluticasone Propionate | 22 | $354 | $16 |
| Montelukast | 35 | $262 | $7 |
| Furosemide | 13 | $80 | $6 |
2016: 15 drugs
| Spiriva | 77 | $41,948 | $545 |
| Advair Diskus | 73 | $30,647 | $420 |
| Dulera | 53 | $16,265 | $307 |
| Symbicort | 29 | $8,389 | $289 |
| Qvar | 21 | $5,187 | $247 |
| Proair Hfa | 40 | $2,395 | $60 |
| Mycophenolate Mofetil | 12 | $1,570 | $131 |
| Sildenafil | 13 | $1,339 | $103 |
| Ventolin Hfa | 15 | $910 | $61 |
| Fluticasone Propionate | 32 | $396 | $12 |
| Montelukast | 51 | $379 | $7 |
| Prednisone | 40 | $364 | $9 |
| Azithromycin | 23 | $239 | $10 |
| Omeprazole | 13 | $59 | $5 |
| Furosemide | 14 | $32 | $2 |
2015: 13 drugs
| Spiriva | 109 | $39,781 | $365 |
| Advair Diskus | 70 | $27,160 | $388 |
| Symbicort | 54 | $14,064 | $260 |
| Proair Hfa | 77 | $4,989 | $65 |
| Daliresp | 14 | $4,376 | $313 |
| Dulera | 13 | $3,681 | $283 |
| Qvar | 15 | $2,833 | $189 |
| Prednisone | 32 | $364 | $11 |
| Montelukast | 33 | $318 | $10 |
| Levofloxacin | 11 | $182 | $17 |
| Azithromycin | 23 | $142 | $6 |
| Fluticasone Propionate | 12 | $111 | $9 |
| Furosemide | 14 | $37 | $3 |
2014: 9 drugs
| Spiriva | 77 | $24,061 | $312 |
| Advair Diskus | 61 | $20,541 | $337 |
| Symbicort | 49 | $11,557 | $236 |
| Qvar | 29 | $5,158 | $178 |
| Proair Hfa | 46 | $2,913 | $63 |
| Prednisone | 20 | $264 | $13 |
| Omeprazole | 17 | $194 | $11 |
| Azithromycin | 15 | $122 | $8 |
| Sulfamethoxazole-Trimethoprim | 11 | $54 | $5 |
2013: 10 drugs
| Advair Diskus | 56 | $20,442 | $365 |
| Spiriva | 31 | $8,176 | $264 |
| Symbicort | 19 | $4,628 | $244 |
| Qvar | 11 | $1,783 | $162 |
| Proair Hfa | 22 | $1,020 | $46 |
| Montelukast | 21 | $789 | $38 |
| Ventolin Hfa | 14 | $523 | $37 |
| Omeprazole | 13 | $224 | $17 |
| Azithromycin | 20 | $180 | $9 |
| Prednisone | 24 | $134 | $6 |
Money from drug and device companies
$22 in 2025
| 2025 | 1 | 1 | None | $22 |
| 2020 | 1 | 1 | None | $15 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Actelion Pharmaceuticals US | Uptravi | $22 | 1 payment
|
See the published payment
| Actelion Pharmaceuticals US | Meals · 2025-05-07 | Uptravi | $22 |
See earlier years (2020)
2020: $15
| AstraZeneca Pharmaceuticals LP | Breztri Aerosphere | $15 | 1 payment
|
Professional record
- NPI
- 1760634141
- Licence
- CA A102212California A102212: Current · expires 2027-12-31
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RP1001X (207RP1001X)
- Mailing address
- Po Box 742502, Los Angeles, CA, 90074
- NPI first listed
- 2008-10-16
- NPI last updated
- 2014-11-04
This is when the NPI record was last certified, not a medical board exam.